Hindsight and Foresight: How Comorbidity Assessment Helps Us in Cancer Care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hindsight and Foresight: How Comorbidity Assessment Helps Us in Cancer Care

Published:2022-07 Issue:7 Volume:34 Page:480-482
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Battisti N.M.L.,Simcock R.

Funder

AbbVie

Novartis

NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

Roche

Abbott Laboratories

Pfizer

Sanofi

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference19 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group;Derks;Br J Cancer,2018

3. Treatment variation in early breast cancer in the UK;Dodwell;BMJ,2020

4. Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial;Crivellari;Breast,2013

5. Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?;Leonard;Br J Cancer,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP